Purpose Fund Corp. – Purpose Core Dividend Fund declares CAD 0.105 dividend
Post Content
Post Content
Post Content Post Views: 117
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024. Post Views: 98
Post Content Post Views: 110
Post Content Post Views: 111
Post Content Post Views: 102
Post Content Post Views: 99